Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis

by Rodrigo Jorge, MD, PhD, Igor Neves Coelho, MD, Armando Silva-Cunha, PhD, Gabriella Maria Fernandes Cunha, PhD, Ingrid U. Scott, MD, MPH, Silvia Ligório Fialho, PhD, João Marcello Furtado, MD, PhD
Published 2021-06-01